Literature DB >> 20463160

The Streptococcus milleri population of a cystic fibrosis clinic reveals patient specificity and intraspecies diversity.

Christopher D Sibley1, Kristen A Sibley, Tara A Leong, Margot E Grinwis, Michael D Parkins, Harvey R Rabin, Michael G Surette.   

Abstract

The genetic relatedness of Streptococcus milleri group isolates from the airways of cystic fibrosis patients was determined by using pulsed-field gel electrophoresis. This study reveals no evidence for patient-to-patient transmission in our patient population; however, within individual patients, complex inter- and intraspecies diversity and dynamics can be observed.

Entities:  

Mesh：

Year:  2010        PMID： 20463160      PMCID： PMC2897483          DOI： 10.1128/JCM.00414-10

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  14 in total

1.  Macrorestriction fingerprinting of "Streptococcus milleri" group bacteria by pulsed-field gel electrophoresis.

Authors:  K L Bartie; M J Wilson; D W Williams; M A Lewis
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

Review 2.  Clinically significant infections with organisms of the Streptococcus milleri group.

Authors:  John Belko; Donald A Goldmann; Ann Macone; Anita K Zaidi
Journal:  Pediatr Infect Dis J       Date:  2002-08       Impact factor: 2.129

3.  Repetitive extragenic palindromic PCR for study of Streptococcus mutans diversity and transmission in human populations.

Authors:  S A Moser; S C Mitchell; J D Ruby; S Momeni; R C Osgood; J Whiddon; N K Childers
Journal:  J Clin Microbiol       Date:  2009-12-09       Impact factor: 5.948

4.  Pulsed-field gel electrophoresis is more discriminating than multilocus enzyme electrophoresis and random amplified polymorphic DNA analysis for typing pyogenic streptococci.

Authors:  F Bert; C Branger; N Lambert-Zechovsky
Journal:  Curr Microbiol       Date:  1997-04       Impact factor: 2.188

5.  Development of real-time PCR assays for detection of the Streptococcus milleri group from cystic fibrosis clinical specimens by targeting the cpn60 and 16S rRNA genes.

Authors:  A B Olson; C D Sibley; L Schmidt; M A Wilcox; M G Surette; C R Corbett
Journal:  J Clin Microbiol       Date:  2010-02-17       Impact factor: 5.948

6.  Characterization of Streptococcus milleri group isolates from expectorated sputum of adult patients with cystic fibrosis.

Authors:  Margot E Grinwis; Christopher D Sibley; Michael D Parkins; Christina S Eshaghurshan; Harvey R Rabin; Michael G Surette
Journal:  J Clin Microbiol       Date:  2009-12-09       Impact factor: 5.948

7.  Prevalence of erythromycin and clindamycin resistance among clinical isolates of the Streptococcus anginosus group in Germany.

Authors:  Nadine Asmah; Bettina Eberspächer; Thomas Regnath; Mardjan Arvand
Journal:  J Med Microbiol       Date:  2009-02       Impact factor: 2.472

8.  A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patients.

Authors:  Christopher D Sibley; Michael D Parkins; Harvey R Rabin; Kangmin Duan; Jens C Norgaard; Michael G Surette
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-23       Impact factor: 11.205

Review 9.  The relevance of the polymicrobial nature of airway infection in the acute and chronic management of patients with cystic fibrosis.

Authors:  Christopher D Sibley; Michael D Parkins; Harvey R Rabin; Michael G Surette
Journal:  Curr Opin Investig Drugs       Date:  2009-08

10.  U.K. Controlled trial of intrapleural streptokinase for pleural infection.

Authors:  Nicholas A Maskell; Christopher W H Davies; Andrew J Nunn; Emma L Hedley; Fergus V Gleeson; Robert Miller; Rhian Gabe; Glyn L Rees; Timothy E A Peto; Mark A Woodhead; Donald J Lane; Janet H Darbyshire; Robert J O Davies
Journal:  N Engl J Med       Date:  2005-03-03       Impact factor: 91.245
View more
  15 in total

Review 1.  Clinical significance of microbial infection and adaptation in cystic fibrosis.

Authors:  Alan R Hauser; Manu Jain; Maskit Bar-Meir; Susanna A McColley
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

Review 2.  The Yin and Yang of Streptococcus Lung Infections in Cystic Fibrosis: a Model for Studying Polymicrobial Interactions.

Authors:  Jessie E Scott; George A O'Toole
Journal:  J Bacteriol       Date:  2019-05-08       Impact factor: 3.490

3.  Pseudomonas aeruginosa Can Inhibit Growth of Streptococcal Species via Siderophore Production.

Authors:  Jessie E Scott; Kewei Li; Laura M Filkins; Bin Zhu; Sherry L Kuchma; Joseph D Schwartzman; George A O'Toole
Journal:  J Bacteriol       Date:  2019-03-26       Impact factor: 3.490

4.  Community Composition Determines Activity of Antibiotics against Multispecies Biofilms.

Authors:  Sarah Tavernier; Aurélie Crabbé; Mayram Hacioglu; Liesbeth Stuer; Silke Henry; Petra Rigole; Inne Dhondt; Tom Coenye
Journal:  Antimicrob Agents Chemother       Date:  2017-08-24       Impact factor: 5.191

Review 5.  Pharmacokinetics and pharmacodynamics of aerosolized antibacterial agents in chronically infected cystic fibrosis patients.

Authors:  Axel Dalhoff
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

Review 6.  Polymicrobial interactions: impact on pathogenesis and human disease.

Authors:  Brian M Peters; Mary Ann Jabra-Rizk; Graeme A O'May; J William Costerton; Mark E Shirtliff
Journal:  Clin Microbiol Rev       Date:  2012-01       Impact factor: 26.132

Review 7.  Cystic fibrosis: a mucosal immunodeficiency syndrome.

Authors:  Taylor Sitarik Cohen; Alice Prince
Journal:  Nat Med       Date:  2012-04-05       Impact factor: 53.440

8.  Structure-Function Characterization of Streptococcus intermedius Surface Antigen Pas.

Authors:  Joshua L Mieher; Norbert Schormann; Ren Wu; Manisha Patel; Sangeetha Purushotham; Hui Wu; Jessica Scoffield; Champion Deivanayagam
Journal:  J Bacteriol       Date:  2021-08-02       Impact factor: 3.490

9.  The adult cystic fibrosis airway microbiota is stable over time and infection type, and highly resilient to antibiotic treatment of exacerbations.

Authors:  Anthony A Fodor; Erich R Klem; Deirdre F Gilpin; J Stuart Elborn; Richard C Boucher; Michael M Tunney; Matthew C Wolfgang
Journal:  PLoS One       Date:  2012-09-26       Impact factor: 3.240

10.  Infection control knowledge, beliefs and behaviours amongst cystic fibrosis patients with epidemic Pseudomonas aeruginosa.

Authors:  R Somayaji; B Waddell; M L Workentine; M G Surette; N P Brager; H R Rabin; M D Parkins
Journal:  BMC Pulm Med       Date:  2015-11-05       Impact factor: 3.317
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.